News & Perspective

Aug 15, 2017

Aug 15, 2017
Tamiflu macro

ECDC experts confirm support for neuraminidase inhibitors

The review didn't find any new evidence to drive policy changes, but said more research and new antivirals are needed.

Sep 09, 2011

Sep 09, 2011

'Contagion' portrays extreme but not impossible scenario

(CIDRAP News) – In the film "Contagion," opening in theaters today, a respiratory virus from Malaysia makes its way from bats to humans, spreading quickly around the world and killing a high proportion of those infected. It's clearly an extreme scenario, but not an impossible one, say experts who have seen the movie.

Jan 28, 2011

Jan 28, 2011

Experts air kinks in antiviral use during H1N1 pandemic

(CIDRAP News) – Although antiviral drugs were used to treat many seriously sick people during the H1N1 influenza pandemic, experts at a conference today said they could have been used more widely and that some opportunities to learn from their use were missed.

Jul 12, 2010

Jul 12, 2010

ICEID COVERAGE Experts air H1N1 lessons, other disease challenges

– ATLANTA (CIDRAP News) – The vital role of preparedness, from diagnostic testing to stockpiling of antiviral medications, was one of the most important lessons from assessments of the world's response to the H1N1 influenza pandemic, the World Health Organization's (WHO's) top flu expert told an international infectious diseases conference yesterday.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 02, 2007

Nov 02, 2007

THE PANDEMIC VACCINE PUZZLE Part 7: Time for a vaccine 'Manhattan Project'?

Editor's note: This is the last in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Bibliography

Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Part 1: Flu research: a legacy of neglect

Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Apr 04, 2007

Apr 04, 2007

NIAID unveils multicenter flu research initiative

(CIDRAP News) – In a major effort to track influenza viruses in nature and learn more about how they interact with the human body, the federal government this week announced a $23-million-a-year program to fund research centers at six institutions around the country.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»